Pharmaceuticals
Healthcare
Tano Capital investing $12.5M to hike stake in Shilpa Medicare
Mumbai-based private equity firm Tano Capital is looking to almost double its holding in Karnataka-based pharmaceutical ingredients manufacturer Shilpa Medicare ......
Healthcare
RBI says non-compete clause for sellers to foreign drugmakers only in special cases
The Reserve Bank of India (RBI) has notified that the non-compete clause will not be applicable in acquisition of existing ......
Healthcare
Lupin ropes in Theresa Stevens to head global M&As
Mumbai-based pharma major Lupin Ltd has appointed Theresa Stevens as chief corporate development officer for its global operations and will ......
Healthcare
Fulcrum eyes 24x in part-exit from dermatology chain Curatio; promoters to exit
Fulcrum Venture India, an SME-focused fund which chases investments in healthcare space, is looking to score a multi-bagger by part ......
Healthcare
Ascent Capital picks minority stake in Alivira Animal Health
Private equity firm Ascent Capital has picked up minority stake in Alivira Animal Health Ltd, which develops, manufactures and sells ......
Healthcare
Dr Datsons Labs in talks with strategic investors for stake sale
Mid-sized drug maker Dr Datsons Labs is negotiating with various pharma companies and other strategic investors for a potential stake ......
Healthcare
Sanofi names N Rajaram as country head for pharma unit in India
Global pharmaceutical major Sanofi has named N Rajaram as the country head and general manager-pharmaceutical operations in India. He would ......
Healthcare
ChrysCapital increases stake in Torrent Pharma
Private equity firm ChrysCapital has upped its investment in Ahmedabad-based drugmaker Torrent Pharmaceuticals Ltd by investing around Rs 70-75 crore ......
Healthcare
Sun Pharma makes open offer for Zenotech
Sun Pharma has made an open offer to buy 28.1 per cent of small sized biotech company Zenotech Laboratories Ltd, ......
Healthcare
Top pharma M&As dominated by MNCs buying into India; Sun breaks the mould
Sun Pharma’s proposed deal to buy out Ranbaxy would not be the first multi-billion dollar transaction for the Indian pharmaceutical ......